1)Narimatsu H, Sawaki H, Kuno A, et al. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010; 277: 95-105
|
|
|
2)Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013; 3: 1065
|
|
|
3)Kaji H, Ocho M, Togayachi A, et al. Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma. J Proteome Res. 2013; 12: 2630-40
|
|
|
4)Ocho M, Togayachi A, Iio E, et al. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. J Proteome Res. 2014; 13: 1428-37
|
|
|
5)Matsuda A, Kuno A, Matsuzaki H, et al. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. J Proteomics. 2013; 85: 1-11
|
|
|
6)Sogabe M, Nozaki H, Tanaka N, et al. Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma. J Proteome Res. 2014; 13: 1624-35
|
|
|
7)Futakawa S, Nara K, Hashimoto Y, et al. A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH. Neurobiol Aging. 2012; 33: 1807-15
|
|
|
8)Shirotani K, Futakawa S, Hashimoto Y, et al. High throughput ELISAs to measure a unique glycan on transferrin in cerebrospinal fluid: A possible extension toward Alzheimerʼs disease biomarker development. Int J Alz Dis. 2011; 5: 2011-6
|
|
|
9)Hoshi K, Kariya Y, Hashimoto Y, et al. Lectin-dependent inhibition of antigen-antibody reaction: application for measuring alpha2,6-sialylated glycoforms of transferrin. J Biochem. 2013; 154: 229-32
|
|
|
10)Komoriya T, Terashima Y, Ogawa M, et al. Development of a high-sensitivity latex reagent for the detection of C-reactive protein. J Immunol Methods. 2011; 373: 4
|
|
|